A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...

Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.

A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...

A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

A common medication used for type 2 diabetes is gaining major attention for a surprising reason. New research suggests ...

Researchers say metformin may mimic some benefits of exercise in prostate cancer patients, helping improve metabolism and manage treatment-related side effects.

Prostate cancer patients treated with the widely prescribed diabetes drug metformin showed elevated blood levels of N-lactoyl ...

Members of the group are participants in LIVESTRONG at the YMCA, a 12-week conditioning program designed to help cancer ...

Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...

A COMMON drug already given to millions of Brits could mimic the effects of “intense” exercise in people who can’t work out, ...

Engaging in moderate to vigorous physical activity, even below recommended levels, can significantly improve cancer survival ...

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...